Jump to section
About this journal
Aims and scope
Future Science OA is an online, open access, peer-reviewed title. The journal covers research and discussion related to advances in biotechnology, medicine and health.
The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal's scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis.
Submissions of the following article types will be considered:
- Research articles
- Preliminary communications
- Short communications
- Methodologies
- Trial design articles
- Trial results (including early-phase and negative studies)
- Reviews
- Perspectives
- Commentaries
Future Science OA provides readers with rigorous publication standards and article production quality, with all articles subject to review by a minimum of three independent experts. The journal follows a gold open access model, publishing all articles under the Creative Commons CC-BY license to allow maximum dissemination. Authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3. The journal is also a member of the Committee on Publication Ethics (COPE).
Articles published in Future Science OA include both unsolicited submissions and articles commissioned by the Editor in collaboration with the Editorial Advisory Board.
Journal metrics
Citation metrics
- 2.4 (2023) Impact Factor
- 2.6 (2023) 5 year IF
- 5.0 (2023) CiteScore (Scopus)
- Q1 CiteScore Best Quartile
- 0.657 (2023) SNIP
- 0.527 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Senior Editors
Ian A Blair, University of Pennsylvania, USA
Editorial Board
Cardiology
Vasilios Athyros, Aristotle University of Thessaloniki, Greece
Catherine Martel, Université de Montréal, Canada - section social media editor
Italo Porto, University of Genova, Italy
Kjell Sakariassen, KellSa s.a.s, Italy
Jaap Jan Zwaginga, Leiden University Medical Center, The Netherlands
Dentistry
Luca Fiorillo, University of Messina, Italy
Dermatology
Kavita Beri, Young Ambassador panel, Jersey Shore University Medical Center, USA -section social media editor
Michael H Gold, Tennessee Clinical Research Center, Gold Skin Care Center, Nashville, TN, USA
Adam J Friedman, George Washington School of Medicine and Health Sciences, Washington, DC, USA
Microbiology & Infectious Disease
Dayle Daines, Old Dominion University, USA
Medicinal Chemistry, Pharmacology & Drug Discovery
George Baillie, University of Glasgow, UK
Jürgen Bajorath,University of Bonn, Germany
Hugo Cerecetto, Universidad de la República, Uruguay
X Margeret Liu, The University of Alabama, USA
Bioengineering, Drug Delivery & Nanotechnology
Raj Bawa,Bawa Biotech LLC, PRI at Albany College of Pharmacy; Guanine, Inc., USA
Marianna Foldvari, University of Waterloo, Canada
Ali Khademhosseini, Terasaki Institute, USA
Jae-Young Lee, Gwangju Institute of Science and Technology, Republic of Korea
Didier Letourneur, CNRS, France
Niren Murthy, University of California at Berkeley, USA
XiuJun (James) Li, University of Texas at El Paso (UTEP), USA
Oncology
Nihat Dilsiz, University of Health Sciences, Turkey
Lev Berstein, Petrov Research Institute of Oncology, St. Petersburg, Russia
Carlo Buonerba, Cancer Center of Excellence of Basilicata (CROB), Italy
Liang Cheng, Indiana University School of Medicine, USA
John Greenman, University of Hull, UK
Simon Lo, University of Washington School of Medicine - Radiation Oncology, Seattle, WA, USA
Srdjan Saso, Imperial College London, UK
J Richard Smith, West London Gynaecological Cancer Centre, UK
Ajay Goel, City of Hope, CA, USA
Immunology
Vito Sabato, University of Antwerp and Antwerp University Hospital, Belgium
Frank Staal, Leiden University Medical Center, The Netherlands
Regenerative Medicine
Chris Mason, University College London, UK
Rupinder Kaur Kanwar , All India Institute of Medical Sciences, India
Biochemistry & Biomarkers
Pablo Moscato, University of Newcastle, Australia
Nate Snyder,Drexel University, USA
Naidong Weng, Janssen Research & Development, USA
Ian Wilson, Imperial College London, UK
Open access
Future Science OA is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
4 issues per year
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors